Editor of ifa James Mitchell is joined by journalist Eliot Hastie to discuss medicinal marijuana and its role within Australia, and how the arrival of companies involved in its production on the stock exchange has opened up the possibility of investing in the drug as an asset class.
Eliot will reveal the surprises that he came across when researching for the story, why Australian stocks within the commodity may not grow at the same rate as has been seen overseas, and how potential legalisation may impact this even further.
